Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk

Gut

Volumn 65, Issue 8, 2016, Pages 1289-1295

  Kantor, Elizabeth D ^a   Udumyan, Ruzan ^b   Signorello, Lisa B ^a   Giovannucci, Edward L ^a,c   Montgomery, Scott ^b,d,e   Fall, Katja ^a,b,e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Örebro University   (Sweden)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOLESCENT OBESITY; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER REGISTRY; CANCER RISK; COLON CANCER; COLORECTAL CANCER; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM CANCER; SWEDE (PEOPLE); BLOOD; COHORT ANALYSIS; COLORECTAL NEOPLASMS; INFLAMMATION; OBESITY; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SWEDEN;

ADOLESCENT; ADULT; BLOOD SEDIMENTATION; BODY MASS INDEX; COHORT STUDIES; COLORECTAL NEOPLASMS; HUMANS; INFLAMMATION; MALE; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SWEDEN;

EID: 84982857134     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-309007     Document Type: Article

References (58)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer, 2013. http://globocan.iarc.fr, accessed on 12/2014.
2. Ning Y, Wang L, Giovannucci EL. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 2010;11:19-30.
3. Bjorge T, Engeland A, Tverdal A, et al. Body mass index in adolescence in relation to cause-specific mortality: A follow-up of 230, 000 Norwegian adolescents. Am J Epidemiol 2008;168:30-7.
4. Burton A, Martin R, Galobardes B, et al. Young adulthood body mass index and risk of cancer in later adulthood: historical cohort study. Cancer Causes Control 2010;21:2069-77.
5. Campbell PT, Cotterchio M, Dicks E, et al. Excess body weight and colorectal cancer risk in Canada: Associations in subgroups of clinically defined familial risk of cancer. Cancer Epidemiol Biomarkers Prev 2007;16:1735-44.
6. Campbell PT, Jacobs ET, Ulrich CM, et al. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 2010;102:391-400.
7. Jeffreys M, Smith GD, Martin RM, et al. Childhood body mass index and later cancer risk: A 50-year follow-up of the Boyd Orr study. Int J Cancer 2004;112:348-51.
8. Lee IM, Paffenbarger RS Jr. Quetelets index and risk of colon cancer in college alumni. J Natl Cancer Inst 1992;84:1326-31.
9. Le Marchand L, Wilkens LR, Mi MP. Obesity in youth and middle age and risk of colorectal cancer in men. Cancer Causes Control 1992;3:349-54.
10. Levi Z, Kark JD, Barchana M, et al. Measured body mass index in adolescence and the incidence of colorectal cancer in a cohort of 1.1 million males. Cancer Epidemiol Biomarkers Prev 2011;20:2524-31.
11. Must A, Jacques PF, Dallal GE, et al. Long-Term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992;327:1350-5.
12. Okasha M, McCarron P, McEwen J, et al. Body mass index in young adulthood and cancer mortality: A retrospective cohort study. J Epidemiol Community Health 2002;56:780-4.
13. Renehan AG, Flood A, Adams KF, et al. Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP Cohort. Am J Epidemiol 2012;176:1130-40.
14. Win AK, Dowty JG, English DR, et al. Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes. Br J Cancer 2011;105:162-9.
15. Han X, Stevens J, Truesdale KP, et al. Body mass index at early adulthood, subsequent weight change and cancer incidence and mortality. Int J Cancer 2014;135:2900-9.
16. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut 2013;62:933-47.
17. Aleksandrova K, Nimptsch K, Pischon T. Obesity and colorectal cancer. Front Biosci (Elite Ed) 2013;5:61-77.
18. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011;140:1807-16.
19. Mariani F, Sena P, Roncucci L. Inflammatory pathways in the early steps of colorectal cancer development. World J Gastroenterol 2014;20:9716-31.
20. Zhou B, Shu B, Yang J, et al. C-reactive protein, interleukin-6 and the risk of colorectal cancer: A meta-Analysis. Cancer Causes Control 2014;25:1397-405.
21. Cai Q, Gao YT, Chow WH, et al. Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk. J Clin Oncol 2006;24:5010-16.
22. Ananthakrishnan AN, Cheng SC, Cai T, et al. Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2014;12:1342-48 e1.
23. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-9.
24. Rothwell PM, Wilson M, Elwin CE, et al. Long-Term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010;376:1741-50.
25. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
26. Terzic J, Grivennikov S, Karin E, et al. Inflammation and colon cancer. Gastroenterology 2010;138:2101-14 e5.
27. Goyal A, Terry MB, Jin Z, et al. C-reactive protein and colorectal cancer mortality in u.s. Adults. Cancer Epidemiol Biomarkers Prev 2014;23:1609-18.
28. Bezawada N, Song M, Wu K, et al. Urinary PGE-M Levels Are Associated with Risk of Colorectal Adenomas and Chemopreventive Response to Anti-Inflammatory Drugs. Cancer Prev Res (Phila) 2014;7:758-65.
29. Shrubsole MJ, Cai Q, Wen W, et al. Urinary prostaglandin E2 metabolite and risk for colorectal adenoma. Cancer Prev Res (Phila) 2012;5:336-42.
30. Sundin PO, Udumyan R, Sjostrom P, et al. Predictors in adolescence of ESRD in middle-Aged men. Am J Kidney Dis 2014;64:723-9.
31. Bergh C, Udumyan R, Fall K, et al. Stress resilience in male adolescents and subsequent stroke risk: cohort study. J Neurol Neurosurg Psychiatry 2014.
32. Montgomery S, Udumyan R, Magnuson A, et al. Mortality following unemployment during an economic downturn: Swedish register-based cohort study. BMJ Open 2013;3:e003031.
33. Backholer K, Pasupathi K, Wong E, et al. The relationship between body mass index prior to old age and disability in old age. Int J Obes (Lond) 2012;36:1180-6.
34. Adams KF, Leitzmann MF, Albanes D, et al. Body mass and colorectal cancer risk in the NIH-AARP cohort. Am J Epidemiol 2007;166:36-45.
35. Jou JM, Lewis SM, Briggs C, et al. ICSH review of the measurement of the erythocyte sedimentation rate. Int J Lab Hematol 2011;33:125-32.
36. Bochen K, Krasowska A, Milaniuk S, et al. Erythrocyte sedimentation rate-An old marker with new applications. J Pre-Clin Clin Res 2011;5:50-5.
37. Sachar DB, Smith H, Chan S, et al. Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J Clin Gastroenterol 1986;8:647-50.
38. Ramsay ES, Lerman MA. How to use the erythrocyte sedimentation rate in paediatrics. Arch Dis Child Educ Pract Ed 2015;100:30-6.
39. Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol 2009;48:27-33.
40. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13.
41. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-81.
42. Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg 2015;150:17-22.
43. Makar KW, Poole EM, Resler AJ, et al. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control 2013;24:2059-75.
44. Slattery ML, Curtin K, Poole EM, et al. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer 2011;128:2726-34.
45. Slattery ML, Wolff RK, Herrick JS, et al. IL6 genotypes and colon and rectal cancer. Cancer Causes Control 2007;18:1095-105.
46. Nimptsch K, Aleksandrova K, Boeing H, et al. Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk. Int J Cancer 2015;136:1181-92.
47. Joshu CE, Tsilidis KK, Peskoe SB, et al. The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation. Cancer Causes Control 2014;25:409-18.
48. Gunter MJ, Cross AJ, Huang WY, et al. A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev 2011;20:537-44.
49. Song M, Wu K, Ogino S, et al. A prospective study of plasma inflammatory markers and risk of colorectal cancer in men. Br J Cancer 2013;108:1891-8.
50. Chan AT, Ogino S, Giovannucci EL, et al. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. Gastroenterology 2011;140:799-808, quiz e11.
51. Fonager K, Sorensen HT, Olsen J. Change in incidence of Crohns disease and ulcerative colitis in Denmark. A study based on the National Registry of Patients, 1981-1992. Int J Epidemiol 1997;26:1003-8.
52. Robsahm TE, Aagnes B, Hjartaker A, et al. Body mass index, physical activity, and colorectal cancer by anatomical subsites: A systematic review and meta-Analysis of cohort studies. Eur J Cancer Prev 2013;22:492-505.
53. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: A meta-Analysis of prospective studies. Am J Clin Nutr 2007;86:556-65.
54. Dirx MJ, van den Brandt PA, Goldbohm RA, et al. Energy restriction early in life and colon carcinoma risk: results of The Netherlands Cohort Study after 7.3 years of follow-up. Cancer 2003;97:46-55.
55. Hughes LA, van den Brandt PA, de Bruine AP, et al. Early life exposure to famine and colorectal cancer risk: A role for epigenetic mechanisms. PLoS ONE 2009;4: e7951.
56. Tuan NT, Wang Y. Adiposity assessments: Agreement between dual-energy X-ray absorptiometry and anthropometric measures in US children. Obesity 2014;22:1495-504.
57. Toss F, Nordstrom A, Nordstrom P. Inflammation in young adulthood is associated with myocardial infarction later in life. Am Heart J 2013;165:164-9.
58. Botteri E, Iodice S, Bagnardi V, et al. Smoking and colorectal cancer: A meta-Analysis. JAMA 2008;300:2765-78.